Therapeutics and COVID-19: Living guideline, 16 September 2022

by admin | 9月 16, 2022 | 臨床指引

666C3023-EC20-459E-A770-0BCD08EA966E

類型: 連結
作者: COVID-19: Clinical care
出處: WHO
連結: https://www.who.int/publications/i/item/WHO-2019-nCoV-therapeutics-2022.5

← Therapeutics and COVID-19: Living guideline, 16 September 2022 Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein →